These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 11141472

  • 1. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.
    Gronert K, Martinsson-Niskanen T, Ravasi S, Chiang N, Serhan CN.
    Am J Pathol; 2001 Jan; 158(1):3-9. PubMed ID: 11141472
    [Abstract] [Full Text] [Related]

  • 2. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
    Fierro IM, Colgan SP, Bernasconi G, Petasis NA, Clish CB, Arita M, Serhan CN.
    J Immunol; 2003 Mar 01; 170(5):2688-94. PubMed ID: 12594298
    [Abstract] [Full Text] [Related]

  • 3. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils.
    Qiu FH, Devchand PR, Wada K, Serhan CN.
    FASEB J; 2001 Dec 01; 15(14):2736-8. PubMed ID: 11687510
    [Abstract] [Full Text] [Related]

  • 4. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
    Takano T, Clish CB, Gronert K, Petasis N, Serhan CN.
    J Clin Invest; 1998 Feb 15; 101(4):819-26. PubMed ID: 9466977
    [Abstract] [Full Text] [Related]

  • 5. Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors.
    McMahon B, Stenson C, McPhillips F, Fanning A, Brady HR, Godson C.
    J Biol Chem; 2000 Sep 08; 275(36):27566-75. PubMed ID: 10869343
    [Abstract] [Full Text] [Related]

  • 6. An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile.
    Schottelius AJ, Giesen C, Asadullah K, Fierro IM, Colgan SP, Bauman J, Guilford W, Perez HD, Parkinson JF.
    J Immunol; 2002 Dec 15; 169(12):7063-70. PubMed ID: 12471142
    [Abstract] [Full Text] [Related]

  • 7. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation.
    Chiang N, Fierro IM, Gronert K, Serhan CN.
    J Exp Med; 2000 Apr 03; 191(7):1197-208. PubMed ID: 10748237
    [Abstract] [Full Text] [Related]

  • 8. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells.
    Ariel A, Chiang N, Arita M, Petasis NA, Serhan CN.
    J Immunol; 2003 Jun 15; 170(12):6266-72. PubMed ID: 12794159
    [Abstract] [Full Text] [Related]

  • 9. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.
    Chiang N, Gronert K, Clish CB, O'Brien JA, Freeman MW, Serhan CN.
    J Clin Invest; 1999 Aug 15; 104(3):309-16. PubMed ID: 10430612
    [Abstract] [Full Text] [Related]

  • 10. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
    Takano T, Fiore S, Maddox JF, Brady HR, Petasis NA, Serhan CN.
    J Exp Med; 1997 May 05; 185(9):1693-704. PubMed ID: 9151906
    [Abstract] [Full Text] [Related]

  • 11. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors.
    Brink C, Dahlén SE, Drazen J, Evans JF, Hay DW, Nicosia S, Serhan CN, Shimizu T, Yokomizo T.
    Pharmacol Rev; 2003 Mar 05; 55(1):195-227. PubMed ID: 12615958
    [Abstract] [Full Text] [Related]

  • 12. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis.
    Hachicha M, Pouliot M, Petasis NA, Serhan CN.
    J Exp Med; 1999 Jun 21; 189(12):1923-30. PubMed ID: 10377187
    [Abstract] [Full Text] [Related]

  • 13. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo.
    Clish CB, O'Brien JA, Gronert K, Stahl GL, Petasis NA, Serhan CN.
    Proc Natl Acad Sci U S A; 1999 Jul 06; 96(14):8247-52. PubMed ID: 10393980
    [Abstract] [Full Text] [Related]

  • 14. Aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogs inhibit neutrophil-mediated changes in vascular permeability.
    Serhan CN, Takano T, Clish CB, Gronert K, Petasis N.
    Adv Exp Med Biol; 1999 Jul 06; 469():287-93. PubMed ID: 10667343
    [No Abstract] [Full Text] [Related]

  • 15. A novel rat lipoxin A4 receptor that is conserved in structure and function.
    Chiang N, Takano T, Arita M, Watanabe S, Serhan CN.
    Br J Pharmacol; 2003 May 06; 139(1):89-98. PubMed ID: 12746227
    [Abstract] [Full Text] [Related]

  • 16. Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function.
    Planagumà A, Domenech T, Jover I, Ramos I, Sentellas S, Malhotra R, Miralpeix M.
    Clin Exp Immunol; 2013 Aug 06; 173(2):298-309. PubMed ID: 23607720
    [Abstract] [Full Text] [Related]

  • 17. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.
    Wan M, Godson C, Guiry PJ, Agerberth B, Haeggström JZ.
    FASEB J; 2011 May 06; 25(5):1697-705. PubMed ID: 21307335
    [Abstract] [Full Text] [Related]

  • 18. Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation.
    Clish CB, Levy BD, Chiang N, Tai HH, Serhan CN.
    J Biol Chem; 2000 Aug 18; 275(33):25372-80. PubMed ID: 10837478
    [Abstract] [Full Text] [Related]

  • 19. Lipoxins and aspirin-triggered lipoxins in airway responses.
    Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt B, Szczeklik W, Drazen JM, Serhan CN.
    Adv Exp Med Biol; 2003 Aug 18; 525():19-23. PubMed ID: 12751730
    [Abstract] [Full Text] [Related]

  • 20. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.
    József L, Zouki C, Petasis NA, Serhan CN, Filep JG.
    Proc Natl Acad Sci U S A; 2002 Oct 01; 99(20):13266-71. PubMed ID: 12235371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.